Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cachexia
- Neoplasms
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02330926
- Collaborators
- Ottawa Regional Cancer Centre
- St. Olavs Hospital
- Oslo University Hospital
- Tumor Zentrum Aarau
- NHS Forth Valley
- Cantonal Hospital of St. Gallen
- Jewish General Hospital
- Cross Cancer Institute
- The Beatson West of Scotland Cancer Centre
- Queen Margaret Hospital, Dunfermline
- Cedars-Sinai Medical Center
- Cancer Research UK Edinburgh Centre
- Guy's and St Thomas' NHS Foundation Trust
- Malteser Krankenhaus Seliger Gerhardt
- Chelsea and Westminister Hospital NHS
- Tumor Biology Center Freiburg
- Investigators
- Study Director: Stein Kaasa, MD PhD European Palliative Care Research Centre (PRC), Department of Cancer Research and Molecular Medicine, Faculty of Medicine, NTNU, Trondheim, Norway Study Director: Marie Fallon, MD PhD Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK